The bear case carries this debate on the weight of its evidence. The technical structure is in a confirmed downtrend (price 10.6% below the 200 SMA with a MACD histogram deepening from -0.31 to -1.50), and the bull's "high-conviction $347 double-floor" hasn't been tested as support once - it's a moving average catching up to price, not institutional accumulation. The fundamentals are deteriorating with alarming velocity: operating margin collapsed from 6.6% to 1.4% in three quarters, free cash flow flipped negative at -$1.1B in Q2 2026 (the first time in the visible period), and EPS actually declined YoY despite 25% revenue growth because 22% share count expansion ate every dollar of incremental profit. The bull's defense of these numbers doesn't survive scrutiny - celebrating capex that burned through FCF, calling 500 bps of margin compression "strategic," and claiming EPS flatness proves "underlying earnings power materially higher" are all inverted readings of the same data. Valuation at 162x forward P/E requires Optimus AND Robovan to both monetize at scale - a joint probability Polymarket puts in the low single digits (8% and 14% respectively). The Polymarket directional skew is the single most damning empirical signal: 30% probability of a $345 September low (trending +19.5pp) versus 5% probability of a $390 high (collapsing -57.5pp) is a 6:1 odds ratio favoring the bear case, and the trend is accelerating in the wrong direction for bulls. The macro regime genuinely is hostile - 30Y yields at 2002 highs, mortgages at 7.58%, and 96% implied probability of no Fed cuts in 2026 - and the bull's claim that this is "fully priced in" misunderstands how discount rates reprice forward-looking multiples continuously. The bull's strongest counters are real but insufficient to flip the conclusion. The $43.5B net cash position is genuinely formidable and prevents a full Sell rating - it provides downside protection, not a bullish catalyst. The Q3 delivery catalyst is imminent and could surprise, but a single beat doesn't reverse a 500 bps margin compression trajectory or repair the structural downtrend. The long-dated optionality from Optimus, the SpaceX merger (64% by 2027), and Robovan has real value but is correctly priced by Polymarket at the probabilities implied. The bull also correctly identifies that sentiment is light bearish, not crowded - which means positioning risk is moderate rather than extreme, but apathy in a downtrend typically resolves in the direction of momentum, which is currently down. With the 200 SMA overhead as resistance, the MACD negative, the FCF negative, the EPS negative on a YoY basis, the Polymarket skew decisively bearish, and the macro offering no relief, the asymmetry favors trimming exposure rather than adding to it. Underweight acknowledges the balance sheet floor and catalyst potential while committing to the side with the stronger empirical case.

POSITION STRATEGY: Trim TSLA exposure to underweight relative to benchmark - reduce position size by 30-40% from typical auto/tech allocation, recognizing that the $43.5B cash fortress prevents a full exit but the deteriorating fundamentals and technical structure warrant reduced exposure.

RISK MANAGEMENT: Set a hard stop at $343 (just below the $347 50 SMA / Bollinger lower band confluence). A clean break below this level with rising volume would confirm the bear case and open the path to a retest of the July low zone at $297-310, representing another 12-15% downside. Do not add to longs on a test of $347 until price reclaims the 200 SMA with a positive MACD histogram.

ENTRY AVOIDANCE: Avoid initiating new long positions at current levels ($352-355). The risk-reward is asymmetric to the downside given: (a) price below the 200 SMA in a confirmed downtrend, (b) negative FCF, (c) 162x forward P/E requiring near-miraculous product execution, and (d) Polymarket skew decisively bearish.

HEDGING: For existing holders, consider a collar structure: sell out-of-the-money calls (strike ~$380, December expiry) against the position to fund protective puts (strike ~$335). This monetizes the elevated implied volatility while defining downside risk, appropriate for a name with real catalyst uncertainty.

CATALYST REASSESSMENT: Use Q3 delivery numbers (early October) as a re-evaluation trigger, but require ALL THREE of the following to consider rebuilding exposure: (a) delivery beat consensus by >5%, (b) reaffirmed or improved gross margin guidance (not further compression), and (c) Polymarket $345 LOW probability dropping below 15% with $390 HIGH probability rising above 20%. A beat on deliveries alone without margin stabilization does not fix the structural problem.

SENTIMENT MONITORING: Monitor Polymarket surface weekly as the highest-signal sentiment gauge: if the $345 LOW probability drops below 15% AND Optimus/Robovan probabilities trend meaningfully higher (>12% / >18% respectively), reassess toward Hold. If the $345 LOW probability rises above 35% with the $390 HIGH probability collapsing below 3%, lean toward Sell.

MACRO WATCH: Any reversal in the 96% no-cuts 2026 pricing (Fed cut probability rising above 20%) would meaningfully reduce the discount rate pressure on the 162x forward multiple and would warrant re-evaluation of the Underweight thesis.

The plan's empirical case for Underweight is overwhelming and internally consistent: confirmed downtrend with price 10.6% below the 200 SMA and a deepening MACD histogram (-0.31 to -1.50) is a textbook technical posture for reducing exposure. Fundamentally, the deterioration is severe - operating margin compressed 500 bps in three quarters (6.6% → 1.4%), Q2 2026 FCF flipped to -$1.1B for the first time in the visible period, and EPS declined YoY despite 25% revenue growth because 22% share count expansion consumed all incremental profit. Valuation at 162x forward P/E requires both Optimus (14%) and Robovan (8%) to monetize at scale per Polymarket - a joint probability in the low single digits. The Polymarket directional skew (30% $345 LOW vs 5% $390 HIGH, a 6:1 ratio with bearish momentum accelerating) is the highest-conviction sentiment signal, and the macro regime (30Y yields at 2002 highs, 96% no-cut probability for 2026) provides no relief valve for that multiple. The $43.5B net cash fortress is the only structural floor and justifies a trim rather than full exit.

Stop loss: $343.00

Sizing: Reduce TSLA exposure by 30-40% from typical auto/tech benchmark allocation; maintain residual position for cash-floor protection and Q3 delivery catalyst optionality